Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Gladman, D D
Fortin, P R
St Pierre, Y
MetadataShow full item record
CitationArthritis Rheum. 2006, 54(8):2550-7
AbstractOBJECTIVE: To examine mortality rates in the largest systemic lupus erythematosus (SLE) cohort ever assembled. METHODS: Our sample was a multisite international SLE cohort (23 centers, 9,547 patients). Deaths were ascertained by vital statistics registry linkage. Standardized mortality ratio (SMR; ratio of deaths observed to deaths expected) estimates were calculated for all deaths and by cause. The effects of sex, age, SLE duration, race, and calendar-year periods were determined. RESULTS: The overall SMR was 2.4 (95% confidence interval 2.3-2.5). Particularly high mortality was seen for circulatory disease, infections, renal disease, non-Hodgkin's lymphoma, and lung cancer. The highest SMR estimates were seen in patient groups characterized by female sex, younger age, SLE duration <1 year, or black/African American race. There was a dramatic decrease in total SMR estimates across calendar-year periods, which was demonstrable for specific causes including death due to infections and death due to renal disorders. However, the SMR due to circulatory diseases tended to increase slightly from the 1970s to the year 2001. CONCLUSION: Our data from a very large multicenter international cohort emphasize what has been demonstrated previously in smaller samples. These results highlight the increased mortality rate in SLE patients compared with the general population, and they suggest particular risk associated with female sex, younger age, shorter SLE duration, and black/African American race. The risk for certain types of deaths, primarily related to lupus activity (such as renal disease), has decreased over time, while the risk for deaths due to circulatory disease does not appear to have diminished.
DescriptionTo access Publisher full text version of this article. Please click on the hyperlink in Additional Link field
- Mortality related to cerebrovascular disease in systemic lupus erythematosus.
- Authors: Bernatsky S, Clarke A, Gladman DD, Urowitz M, Fortin PR, Barr SG, Senécal JL, Zummer M, Edworthy S, Sibley J, Pope J, Ensworth S, Ramsey-Goldman R, Hanly JG
- Issue date: 2006
- Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95.
- Authors: Björnådal L, Yin L, Granath F, Klareskog L, Ekbom A
- Issue date: 2004 Apr
- Incidence and mortality of systemic lupus erythematosus in a southern Chinese population, 2000-2006.
- Authors: Mok CC, To CH, Ho LY, Yu KL
- Issue date: 2008 Oct
- Racial aspects of comorbidity in systemic lupus erythematosus.
- Authors: Walsh SJ, Algert C, Rothfield NF
- Issue date: 1996 Dec
- Mortality and cancer incidence in Korean patients with systemic lupus erythematosus: results from the Hanyang lupus cohort in Seoul, Korea.
- Authors: Chun BC, Bae SC
- Issue date: 2005